中国现代神经疾病杂志 ›› 2015, Vol. 15 ›› Issue (2): 142-147. doi: 10.3969/j.issn.1672-6731.2015.02.011

• 脑血管病临床研究 • 上一篇    下一篇

2 小骨窗开颅治疗非进展性跨窦硬膜外血肿

胡连水, 王文浩, 林洪, 林俊明, 李君, 罗飞, 张源   

  1. 363000 漳州,解放军第一七五医院暨厦门大学附属东南医院神经外科 南京军区神经外科创伤中心
  • 出版日期:2015-02-25 发布日期:2015-02-24
  • 通讯作者: 王文浩 (Email:wenhao_wang0712@126.com)

The clinical efficacy of small-window craniotomy on non-progressive trans-sinus epidural hematoma

HU Lian-shui, WANG Wen-hao, LIN Hong, LIN Jun-ming, LI Jun, LUO Fei, ZHANG Yuan   

  1. Department of Neurosurgery, the 175th Hospital of Chinese PLA, Affiliated Southeast Hospital of Xiamen University; Center of Traumatic Neurosurgery in Nanjing Military Command, Zhangzhou 363000, Fujian, China
  • Online:2015-02-25 Published:2015-02-24
  • Contact: WANG Wen-hao (Email: wenhao_wang0712@126.com)

摘要: 目的 比较跨窦小骨窗颅骨切开术(小骨窗手术)与幕上-幕下联合颅骨切开术(常规手术)清除非进展性跨窦硬膜外血肿的手术效果。方法 共67 例非进展性跨窦硬膜外血肿患者分别采用两种手术方式清除血肿,比较两组患者术后窦旁血肿残留量、颅内压变化、静脉窦通畅情况、住院时间,以及术后6 个月时Glasgow 预后分级(GOS)评分。结果 与常规手术组相比,小骨窗手术组患者术后窦旁血肿残留量[(1.40 ± 1.60)ml 对(3.50 ± 2.10)ml,P = 0.000]和住院时间[(13.40 ± 5.70)d 对(17.30 ± 7.00)d,P = 0.015]减少,术后颅内压[1 d:(164.40 ± 33.30)mm H2O 对(198.60 ± 49.30)mm H2O,P = 0.002;3 d:(185.90 ± 47.80)mm H2O 对(226.30 ± 81.60)mm H2O,P = 0.017;7 d:(154.70 ± 52.50)mm H2O 对(198.30 ± 84.20)mm H2O,P = 0.014]降低,术后静脉窦通畅率提高(87.50%对65.70%,P = 0.037)。两组患者术后6 个月GOS 评分差异无统计学意义(Z = -0.114,P = 0.909)。结论 跨窦小骨窗颅骨切开术可有效清除非进展性跨窦硬膜外血肿,尤其是窦旁血肿清除较彻底,可有效解除静脉窦受压、改善静脉窦回流障碍、降低颅内压,是清除非进展性跨窦硬膜外血肿的可靠术式。

关键词: 血肿, 硬膜外, 颅内, 颅骨切开术

Abstract: Objective  To investigate the clinical efficacy of two surgical approaches, trans-sinus small-window craniotomy (TSSWCT) and combined supratentorial-infratentorial craniotomy (CSITCT), on non-progressive trans-sinus epidural hematoma.  Methods  There were 67 patients with non-progressive trans-sinus epidural hematoma who underwent TSSWCT or CSITCT. The postoperative residual hematoma, postoperative alteration of intracranial pressure (ICP), recanalization of affected cerebral venous sinuses, length of hospitalization, and 6-month Glasgow Outcome Scale (GOS) score of patients were retrospectively compared.  Results Compared with patients in the CSITCT group (N = 35), those in the TSSWCT group (N = 32) had significantly reduced postoperative residual hematoma near the venous sinus [(1.40 ± 1.60) ml vs (3.50 ± 2.10) ml, P = 0.000], length of hospitalization [(13.40 ± 5.70) d vs (17.30 ± 7.00) d, P = 0.015], markedly down-regulated levels of intracranial pressure (ICP) at indicated postoperative time points [1 d: (164.40 ± 33.30) mm H2O vs (198.60 ± 49.30) mm H2O, P = 0.002; 3 d: (185.90 ± 47.80) mm H2O vs (226.30 ± 81.60) mm H2O, P = 0.017; 7 d: (154.70 ± 52.50) mm H2O vs (198.30 ± 84.20) mm H2O, P = 0.014)], and distinctly improved recanalization of affected cerebral venous sinuses (87.50% vs 65.70% , P = 0.037). Moreover, the 6-month GOS scores were not statistically different between patients in 2 groups (Z = -0.114, P = 0.909).  Conclusions  Compared with CSITCT, TSSWCT is a reliable surgical approach in the treatment of non-progressive trans-sinus epidural hematoma which has strengthened capability of evacuating hematoma underlying affected venous sinuses, relieving the compressed venous sinus and attenuating the intracranial hypertension.

Key words: Hematoma, epidural, cranial, Craniotomy